Patient Rights Directory Resources

Submit URL Patient Rights

Patient Rights News

07.10.2008 - DJ HUGIN NEWS/Patient treatment in phase III study with BF-200 ALA for actinic keratosis completed (4investors)

Corporate news announcement processed and transmitted by Hugin ASA. The issuer is solely responsible for the content of this announcement. =--------------------------------------------------------------------- =-------------

Proposed bill would be boon to unions (MSNBC)

The Employee Free Choice Act could speed up the process of forming a union by allowing workers to bypass a formal vote and imposing hefty fines on employers that violate employee rights.

Rights begin with human life (The Evening Sun)

In response to Mr. Fred Schaff's letter, Sept. 21, summing up "the beliefs of a majority of Americans" and not believing life begins at conception. At one time consensus was that the world was flat, that slaves could be held, and women couldn't vote.

(AFX UK Focus) 2008-10-08 06:50 UPDATE 1-Novartis says Glivec has potential to treat PAH (Interactive Investor)

ZURICH, Oct 8 (Reuters) - Novartis AG's cancer drug Glivec had the potential to treat a rare heart and lung condition in a mid-stage trial, but did not reach its main target in the study. Preliminary findings from the 59-patient study suggested Glivec, known also by its generic name imatinib, provided a treatment benefit in key measures used to monitor the progression of the disease, pulmonary ...

Biolex Therapeutics Enters Into Agreement to Acquire Full Locteron(R) Commercial Rights (Marketwire via Yahoo! Finance)

Biolex Therapeutics, Inc. announced that it has entered into an agreement with OctoPlus N.V. to acquire OctoPlus' 50 percent share of commercial rights to the Locteron product candidate for hepatitis C.